Hyperthermia and hypoxia: new developments in anticancer chemotherapy
- 1 June 2001
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (4) , 340-342
- https://doi.org/10.1053/ejso.2000.1040
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancerAnnals of Oncology, 1999
- An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancerGene Therapy, 1999
- Invited Review: For the clinical application of thermochemotherapy given at mild temperaturesInternational Journal of Hyperthermia, 1999
- Bioreductive therapies: an overview of drugs and their mechanisms of actionInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cellsCell Proliferation, 1995
- Hyperthermia and platinum complexes: Time between treatments and synergyin vitroandin vivoInternational Journal of Hyperthermia, 1995
- RELEVANCE OF CELL KINETIC AND PLOIDY CHARACTERISTICS FOR THE THERMAL RESPONSE OF MALIGNANT-MELANOMA PRIMARY CULTURESInternational Journal of Oncology, 1993
- Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanomaInternational Journal of Hyperthermia, 1992
- Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanomaThe International Journal of Cell Cloning, 1989